Anemia in Chronic Kidney Disease

Pharmacists play a crucial role on the health care team and are critical to improving slowing the progression of CKD. Yet, many pharmacists are not adequately trained in evaluation or management of CKD. This activity is part of a series that will build pharmacists knowledge of the anatomy and physiology of the kidney, the pathophysiology of CKD, strategies for slowing progression and managing complications of CKD, and applications of medication therapy management in CKD. Additionally, this activity will enable pharmacists to apply their new knowledge to medication therapy management for patients with CKD. This activity – module 3 of the series – will discuss management of anemia in CKD.  

Target Audience

  • Pharmacists
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; complete the pre-test; review the video content; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.

Learning Objectives

After participation in this activity, learners will be better able to:

  • Describe applications of erythropoiesis and iron metabolism in treating anemia of CKD and the role of the pharmacist in addressing current controversies in care
  • Discuss how laboratory, clinical, and medication data and are used to assess and monitor anemia in chronic kidney disease (CKD) and identify optimal management strategies 
  • Review the key differences in formulation, pharmacokinetics, pharmacodynamics and immunogeneticity between the available intravenous iron products
  • Integrate the erythropoiesis stimulating agent (ESA) evidence-base into care paradigms for different CKD settings (e.g. pre-dialysis vs. dialysis vs. transplant) 
Course summary
Available credit: 
  • 1.00 Attendance
  • 1.00 ACPE Contact Hours
Course opens: 
Course expires: 
Faculty Disclosures

Amy Barton Pai, PharmD, MHI, FASN, FCCP, FNKF
Associate Professor
University of Michigan
Ann Arbor, MI
Disclosure: Consulting Fees: Keryx, Subject: Anemia

Andrew Narva, MD
National Kidney Disease Education Program, NIDDKM, NIH
Bethesda, MD
Disclosure: Has no financial relationships with commercial interest(s).

Planning Committee Disclosures

Jenna Norton, MPH
Associate Director 
National Institute of Diabetes and Digestive and Kidney Disease        
Arlington, VA
Disclosure: Has no financial relationships with commercial interest(s).

Soo Min Jang, PharmD
Assistant Professor
Loma Linda University
Anaheim, CA
Disclosure: Has no financial relationships with commercial interest(s).

Jessica Joseph, MBA
Senior Vice President, Scientific Operations
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Danielle Nathan, MA
Senior Director, Professional Education
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Senior Continuing Medical Education Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Brianna Burge, BS
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.



This knowledge-based enduring activity has been assigned Universal Activity Number JA0004461-0000-20-032-H04-P, for 1.0 contact hours (0.01 CEUs). To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit:



Available Credit

  • 1.00 Attendance
  • 1.00 ACPE Contact Hours


Please login or register for a PERC account to take this course.


The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit

For additional professional education resources, contact NKF at 1-800-622-9010 or visit